PULMATRIX, INC. Derivative Liability, Noncurrent
PULMATRIX, INC. (PULM) had Derivative Liability, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2019-02-19
- 2018-12-31: Derivative Liability, Noncurrent $0.00.
- 2017-12-31: Derivative Liability, Noncurrent $1.00K.
- 2017-09-30: Derivative Liability, Noncurrent $35.00K.
- 2017-06-30: Derivative Liability, Noncurrent $35.00K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-19 |
| 2017-12-31 | $1.00K 10-K · filed 2019-02-19 |
| 2017-09-30 | $35.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $35.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $35.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $35.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $11.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $11.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $11.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $11.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $11.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $11.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |